Studies from AD patients, patient-derived stem cell models and human APOE4-expressing and APOE-deficient mouse models have demonstrated that APOE4 provokes neuroinflammation, impairs vascular function and exacerbates Aβ and tau pathology [96]. This evidence concerns the gene MAPT and Alzheimer disease.